Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

VICL Insider Trading

VICL | Market Equity

Comprehensive Trading Performance Summary

The investment history of corporate insiders at VICL provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2014-10-15 01:46 2014-10-13 BILINSKY IGOR Officer - Sr VP, Corporate Development SELL $1.08 1,335 $1,446 127,648 -1.0%
2014-10-15 01:47 2014-10-13 SAMANT VIJAY B Director, Officer - President & CEO SELL $1.13 4,738 $5,353 936,513 -0.5%
2014-08-27 20:55 2014-08-26 SMITH LAWRENCE RUSSELL Officer - VP, Vaccine Research SELL $1.25 12,500 $15,674 178,801 -6.5%
2014-08-27 20:55 2014-08-26 BILINSKY IGOR Officer - Senior VP, Corporate Dev't SELL $1.25 12,500 $15,671 128,983 -8.8%
2014-08-27 20:54 2014-08-26 Ramos Anthony Alan Officer - VP, Chief Accounting Officer SELL $1.25 12,500 $15,675 88,364 -12.4%
2014-07-22 01:06 2014-07-21 Ramos Anthony Alan Officer - VP, Chief Accounting Officer SELL $1.29 428 $552 100,864 -0.4%
2014-07-15 18:24 2014-07-11 SMITH LAWRENCE RUSSELL Officer - VP, Vaccine Research SELL $1.16 1,912 $2,225 191,301 -1.0%
2014-07-15 18:25 2014-07-11 BILINSKY IGOR Officer - Senior VP, Corporate Dev't SELL $1.16 1,335 $1,554 141,483 -0.9%
2014-07-15 18:25 2014-07-14 SAMANT VIJAY B Director, Officer - President & CEO SELL $1.17 4,737 $5,544 941,251 -0.5%
2014-01-14 21:28 2014-01-10 SMITH LAWRENCE RUSSELL Officer - VP, Vaccine Research BUY $1.42 90,000 $127,800 197,422 +83.8%
2014-01-14 21:28 2014-01-10 BILINSKY IGOR Officer - Senior VP, Corporate Dev't BUY $1.42 90,000 $127,800 145,692 +161.6%
2014-01-14 21:29 2014-01-10 Ramos Anthony Alan Officer - Chief Accounting Officer BUY $1.42 70,000 $99,400 102,339 +216.5%
2014-01-14 21:34 2014-01-10 SAMANT VIJAY B Director, Officer - President & CEO BUY $1.42 330,000 $468,600 962,211 +52.2%
2013-11-15 00:27 2013-11-12 Ramos Anthony Alan Officer - Chief Accounting Officer SELL $1.11 7,918 $8,789 32,339 -19.7%
2013-09-13 00:15 2013-09-12 SINGER JAMES R 10% owner SELL $1.29 200,000 $257,720 8,670,000 -2.3%
2013-09-12 23:36 2013-09-11 SINGER JAMES R 10% owner SELL $1.30 300,000 $389,820 8,870,000 -3.3%
2013-09-12 18:12 2013-09-10 SINGER JAMES R 10% owner SELL $1.23 200,000 $245,360 9,170,000 -2.1%
2013-09-10 15:46 2013-09-09 SINGER JAMES R 10% owner SELL $1.22 200,000 $244,020 9,370,000 -2.1%
2013-09-05 01:08 2013-09-03 SINGER JAMES R 10% owner SELL $1.24 466,000 $577,654 9,570,000 -4.6%
2013-09-03 21:17 2013-08-30 SINGER JAMES R 10% owner SELL $1.31 84,000 $109,670 10,036,000 -0.8%
2013-08-30 21:38 2013-08-29 SINGER JAMES R 10% owner SELL $1.30 150,000 $195,390 10,120,000 -1.5%
2013-08-30 21:27 2013-08-28 SINGER JAMES R 10% owner SELL $1.31 200,000 $261,780 10,270,000 -1.9%
2013-08-27 20:13 2013-08-26 Ramos Anthony Alan Officer - Chief Accounting Officer BUY $0.01 25,000 $250 40,665 +159.6%
2013-05-29 01:41 2013-05-23 Beleson Richard M Director BUY $0.01 7,003 $70 7,078 +9,337.3%
2013-05-29 01:40 2013-05-23 MERTON ROBERT C Director BUY $0.01 5,953 $60 75,781 +8.5%
2013-05-29 01:40 2013-05-23 DOUGLAS R GORDON Director BUY $0.01 5,953 $60 93,281 +6.8%
2013-05-29 01:41 2013-05-23 LYONS GARY A Director BUY $0.01 5,953 $60 63,281 +10.4%
2013-05-29 01:42 2013-05-23 SHERWIN STEPHEN A Director BUY $0.01 7,003 $70 7,003 +100.0%
2013-05-29 01:41 2013-05-23 MORROW GEORGE J Director BUY $0.01 5,953 $60 12,347 +93.1%
2013-01-16 00:14 2013-01-11 Broadfoot Jill Marie Officer - Sr Vice President, CFO, Sec BUY $0.01 27,060 $271 234,935 +13.0%
2013-01-16 00:16 2013-01-11 SAMANT VIJAY B Director, Officer - President & CEO BUY $0.01 84,600 $846 654,424 +14.8%
2013-01-16 00:09 2013-01-11 ROLLAND ALAIN P PHD Officer - Exec VP, Product Development BUY $0.01 22,092 $221 182,023 +13.8%
2013-01-15 19:00 2012-09-04 SINGER JAMES R 10% owner BUY $3.99 154,333 $615,573 10,470,000 +1.5%
2013-01-15 18:29 2012-07-19 SINGER JAMES R 10% owner BUY $3.51 310,000 $1,087,108 10,315,667 +3.1%
2012-10-17 21:22 2012-10-15 MORROW GEORGE J Director BUY $0.01 6,394 $64 6,394 +100.0%
2012-05-30 00:51 2012-05-24 MERTON ROBERT C Director BUY $0.01 7,328 $73 57,328 +14.7%
2012-05-30 00:51 2012-05-24 DOUGLAS R GORDON Director BUY $0.01 7,328 $73 87,328 +9.2%
2012-05-30 00:50 2012-05-24 LYONS GARY A Director BUY $0.01 7,328 $73 57,328 +14.7%
2012-05-30 00:50 2012-05-24 CAMPBELL ROBERT H Director BUY $0.01 7,328 $73 58,328 +14.4%
2012-01-18 23:30 2012-01-13 Broadfoot Jill Marie Officer - Sr Vice President, CFO, Sec BUY $0.01 27,000 $270 207,875 +14.9%
2012-01-18 23:30 2012-01-13 SAMANT VIJAY B Director, Officer - President & CEO BUY $0.01 67,000 $670 582,726 +13.0%
2012-01-18 23:29 2012-01-13 ROLLAND ALAIN P PHD Officer - Exec VP, Product Development BUY $0.01 27,000 $270 171,563 +18.7%
2012-01-10 00:05 2012-01-06 SINGER JAMES R 10% owner BUY $3.75 2,666,667 $10,000,001 10,005,667 +36.3%
2012-01-06 23:56 2012-01-04 SINGER JAMES R 10% owner BUY $4.37 72,000 $314,554 7,339,000 +1.0%
2011-05-31 19:50 2011-05-26 MERTON ROBERT C Director BUY $0.01 18,750 $188 50,000 +60.0%
2011-05-31 19:38 2011-05-26 DOUGLAS R GORDON Director BUY $0.01 30,000 $300 80,000 +60.0%
2011-05-31 19:21 2011-05-26 LYONS GARY A Director BUY $0.01 18,750 $188 50,000 +60.0%
2011-05-31 19:44 2011-05-26 CAMPBELL ROBERT H Director BUY $0.01 18,750 $188 51,000 +58.1%
2011-02-04 22:05 2011-02-04 SAMANT VIJAY B Director, Officer - President & CEO BUY $1.99 500 $995 526,263 +0.1%
2011-01-25 23:32 2011-01-21 SAMANT VIJAY B Director, Officer - President & CEO BUY $2.00 500 $1,000 525,763 +0.1%
SHOW ENTRIES

How to Interpret $VICL Trades

Not every insider transaction in VICL is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $VICL shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for VICL

Insider activity data for VICL is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $VICL, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.